Percutaneous tibial nerve stimulation: The urgent PC® device

Expert Review of Medical Devices

Volumn 4, Issue 5, 2007, Pages 693-698

  van Balken, Michael R ^a  

^a RIJNSTATE HOSPITAL   (Netherlands)

Author keywords

Chronic pelvic pain; Incontinence; Lower urinary tract disorders; Neuromodulation; Overactive bladder; Percutaneous tibial nerve modulation; Urinary retention

Indexed keywords

BOTULINUM TOXIN;

ARTICLE; BLADDER CATHETERIZATION; BLADDER EMPTYING; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; ELECTRIC CURRENT; ELECTRODE; HUMAN; LOWER URINARY TRACT SYMPTOM; MAINTENANCE THERAPY; MEDICAL INSTRUMENTATION; MICTURITION DISORDER; NERVE CELL PLASTICITY; NERVE STIMULATION; NEUROMODULATION; NONHUMAN; OUTCOME ASSESSMENT; OVERACTIVE BLADDER; PATIENT POSITIONING; PATIENT SAFETY; PROGNOSIS; QUALITY OF LIFE; RECURRENT DISEASE; RETREATMENT; SPINAL REFLEX; TIBIAL NERVE; TREATMENT DURATION; TREATMENT INDICATION;

HUMANS; TIBIAL NERVE; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION; URINATION DISORDERS;

EID: 34848821162     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/17434440.4.5.693     Document Type: Article

References (53)

1. Hasan ST, Robson WA, Pridie AK et al. Transcutaneous electrical nerve stimulation and temporary S3 neuromodulation in idiopathic detrusor instability. J. Urol. 155, 2005-2011 (1996).
2. Leippold T, Reitz A, Schurch B. Botulinum toxin as a new therapy option for voiding disorders: current state of the art. Eur. Urol. 44, 165-174 (2003).
3. Rajkumar GN, Small DR, Mustafa AW et al. A prospective study to evaluate the safety, tolerability, efficacy and durability of response of intravesical injection of botulinum toxin type A into detrusor muscle in patients with refractory idiopathic detrusor overactivity. BJU Int. 96, 848-852 (2005).
4. Tanagho EA, Schmidt RA. Electrical stimulation in the clinical management of the neurogenic bladder. J. Urol. 140, 1331-1339 (1988).
5. Hassouna MM, Siegel SW, Nyeholt AA et al. Sacral neuromodulation in the treatment of urgency-frequency symptoms: a multicenter study on efficacy and safety. J. Urol. 163, 1849-1854 (2000).
6. Jonas U, Fowler CJ, Chancellor MB et al. Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation. J. Urol. 165, 15-19 (2001).
7. McGuire EJ, Zhang SC, Horwinski ER et al. Treatment of motor and sensory detrusor instability by electrical stimulation. J. Urol. 121, 78-79 (1983).
8. Stoller ML, Copeland S, Millard AR et al. The efficacy of acupuncture in reversing unstable bladder in pig-tailed monkeys. [Abstract 2]. J. Urol. (Suppl. 137), 104A (1987).
9. Stoller ML. Afferent nerve stimulation for pelvic floor dysfunction. [Abstract 62]. Eur. Urol. 35(Suppl. 2), 16 (1999).
10. Govier FE, Litwiller S, Nitti V et al. Percutaneous afferent neuromodulation for the refractory overactive bladder: results of a multicenter study. J. Urol. 165, 1193-1198 (2001).
11. Alo K, Holsheimer J. New trends in neuromodulation for the management of neuropathic pain. Neurosurgery 50, 690-703 (2002).
12. Schmidt R. Advances in genitourinary neurostimulation. Neurosurgery 19, 1041-1044 (1986).
13. Peeren F, Hoebeke P, Everaert K. Sacral nerve stimulation: InterStim® therapy. Expert Rev. Med. Devices 2(3), 253-258 (2005).
14. Goodwin R, Swinn M, Fowler C. The neurophysiology of urinary retention in young women and its treatment by neuromodulation. World J. Urol. 16, 305-307 (1998).
15. Schultz-Lampel D, Jiang C, Lindstrom S et al. Experimental results on mechanisms of action on electrical neuromodulation in chronic urinary retention. World J. Urol. 16, 301-304 (1998).
16. van Balken MR, Vergunst H, Bemelmans BL. The use of electrical devices for the treatment of bladder dysfunction: a review of methods. J. Urol. 172, 846-851 (2004).
17. Bemelmans BL, Mundy A, Craggs M. Neuromodulation by implant for treating lower urinary tract symptoms and dysfunction. Eur. Urol. 36, 81-91 (1999).
18. van der Pal F, Heesakkers JP, Bemelmans BL. Current opinion on the working mechanisms of neuromodulation in the treatment of lower urinary tract dysfunction. Curr. Opin. Urol. 16, 261-267 (2006).
19. van Balken MR, Vandoninck V, Gisolf KW et al. Posterior tibial nerve stimulation as neuromodulative treatment of lower urinary tract dysfunction. J. Urol. 166, 914-918 (2001).
20. Vandoninck V, van Balken MR, Finazzi Agro E et al. Posterior tibial nerve stimulation in the treatment of idiopathic nonobstructive voiding dysfunction. Urology 61, 567-572 (2003).
21. Vandoninck V, van Balken MR, Agro EF et al. Posterior tibial nerve stimulation in the treatment of urge incontinence. Neurourol. Urodyn. 22, 17-23 (2003).
22. Klingler HC, Pycha A, Schmidbauer J et al. Use of peripheral neuromodulation of the S3 region for treatment of detrusor overactivity: a urodynamic-based study. Urology 56, 766-771 (2000).
23. Ruiz BC, Pena OX, Martinez PC et al. Peripheral afferent nerve stimulation for treatment of lower urinary tract irritative symptoms. Eur Urol. 45, 65-69 (2004).
24. van Balken MR, Vandoninck V, Messelink EJ et al. Percutaneous tibial nerve stimulation as neuromodulative treatment of chronic pelvic pain. Eur. Urol. 43, 158-163 (2003).
25. Fjorback MV, van Rey FS, van der Pal F et al. Acute urodynamic effects of posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with MS. Eur. Urol. 51, 464-472 (2007).
26. Vandoninck V, van Balken MR, Finazzi Agro E et al. Percutaneous tibial nerve stimulation in the treatment of overactive bladder: urodynamic data. Neurourol. Urodyn. 22, 227-232 (2003).
27. Vandoninck V, van Balken MR, Finazzi Agro E et al. Posterior tibial nerve stimulation in the treatment of voiding dysfunction: urodynamic data. Neurourol. Urodyn. 23, 246-251 (2004).
28. Janknegt RA, Hassouna MM, Siegel SW et al. Long-term effectiveness of sacral nerve stimulation for refractory urge incontinence. Eur. Urol. 39, 101-106 (2001).
29. Koldewijn EL, Rosier PF, Meuleman EJ et al. Predictors of success with neuromodulation in lower urinary tract dysfunction: results of trial stimulation in 100 patients. J. Urol. 152, 2071-2075 (1994).
30. Weil EH, Ruiz-Cerda JL, Eerdmans PH et al. Clinical results of sacral neuromodulation for chronic voiding dysfunction using unilateral sacral foramen electrodes. World J. Urol. 16, 313-321 (1998).
31. Bosch JL, Groen J. Disappointing results of neuromodulation in men with urge incontinence due to detrusor instability. Neurourol. Urodyn. 16, 347-349 (1997).
32. Spinelli M, Bertapelle P, Cappellano F et al. Chronic sacral neuromodulation in patients with lower urinary tract symptoms: results from a national register. J. Urol. 166, 541-545 (2001).
33. Rosier PF, Meuleman EJ, Debruyne FM. Quality of life of patients with lower urinary tract dysfunction after treatment with sacral neuromodulation. Neurourol. Urodyn. 16, 483-484 (1997).
34. van Balken MR, Vergunst H, Bemelmans BL. Prognostic factors for successful percutaneous tibial nerve stimulation. Eur. Urol. 49, 360-365 (2006).
35. Van der Pal F, van Balken MR, Heesakkers JP et al. Percutaneous tibial nerve stimulation (PTNS) in the treatment of refractory overactive bladder syndrome: is maintenance treatment a necessity? BJU Int. 97, 547-550 (2006).
36. Van der Pal F, van Balken MR, Heesakkers JP et al. Implant driven tibial nerve stimulation in the treatment of refractory overactive bladder syndrome: 12-month follow up. Neuromodulation 9, 163-171 (2006).
37. Bosch JL. The bion device: a minimally invasive implantable ministimulator for pudendal nerve neuromodulation in patients with detrusor overactivity incontinence. Urol. Clin. North Am. 32, 109-112 (2005).
38. Groen J, Amiel C, Bosch JL. Chronic pudendal nerve neuromodulation in women with idiopathic refractory detrusor overactivity incontinence: results of a pilot study with a novel minimally invasive implantable mini-stimulator. Neurourol. Urodyn. 24, 226-230 (2005).
39. Chang CJ, Huang ST, Hsu K et al. Electroacupuncture decreases c-fos expression in the spinal cord induced by noxious stimulation of the rat bladder. J. Urol. 160, 2274-2279 (1998).
40. Van der Pal F, Heesakkers JP, Debruyne FM et al. Modulation of the micturition reflex in an anestetized cat through percutaneous stimulation of the tibial nerve. Eur. Urol. (Suppl. 4), 193 (2005).
41. Guys JM, Haddad M, Planche D et al. Sacral neuromodulation for neurogenic bladder dysfunction in children. J. Urol. 172, 1673-1676 (2004).
42. Hoebeke P, Renson C, Petillon L et al. Percutaneous electrical nerve stimulation in children with resistant nonneuropathic bladder sphincter dysfunction: a pilot study. J. Urol. 168, 2605-2607 (2002).
43. De Gennaro M, Capitanucci ML, Mastracci P et al. Percutaneous tibial nerve stimulation is well tolerated in children and effective for treating refractory vesical dysfunction. J. Urol. 171, 1911-1913 (2004).
44. Bosch JL, Groen J. Treatment of refractory urge urinary incontinence with sacral spinal nerve stimulation in multiple sclerosis patients Lancet 348, 717-719 (1990).
45. Chartier-Kastler EJ, Bosch JL, Perrigot M et al. Long-term results of sacral nerve stimulation (S3) for the treatment of neurogenic refractory urge incontinence related to detrusor hyperreflexia. J. Urol. 164, 1476-1480 (2000).
46. Lavano A, Volpentesta G, Aloisi M et al. Use of chronic sacral nerve stimulation in neurological voiding disorders. J. Neurosurg. Sci. 48, 157-159 (2004).
47. Jarrett ME, Mowatt G, Glazener CM et al. Systematic review of sacral nerve stimulation for faecal incontinence and obstipation. Br. J. Surg. 91. 1559-1569 (2004).
48. Shafik A, Ahmed I, El-Sibai O et al. Percutaneous peripheral neuromodulation in the treatment of fecal incontinence. Eur. Surg. Res. 35, 103-107 (2003).
49. Finazzi Agro E, Campagna A, Sciobica F et al. Posterior tibial nerve stimulation: is the once-a-week protocol the best option? Minerva Urol. Nefrol. 57, 119-123 (2005).
50. Fall M, Lindstrom S. Electrical stimulation. A physiologic approach to the treatment of urinary incontinence. Urol. Clin. North Am. 18, 393-407 (1991).
51. Hohenfellner M, Schultz-Lampel D, Dahms S et al. Bilateral chronic sacral neuromodulation for treatment of lower urinary tract dysfunction. J. Urol. 160, 821-824 (1998).
52. Scheepens WA, De Bie RA, Weil EH et al. Unilateral versus bilateral sacral neuromodulation in patients with chronic voiding dysfunction. J. Urol. 168, 2046-2050 (2002).
53. Van Kerrebroeck EV, Scheepens WA, de Bie RA et al. European experience with bilateral sacral neuromodulation in patients with chronic lower urinary tract dysfunction. Urol. Clin. North Am. 32, 51-57 (2005).